(1978). Albers JJ: A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high densitylipoproteincholesterol.JLipidRes 19:65–76,
(2000). Alderman MH: Serum uric acid and cardiovascular mortality: the NHANES I Epidemiologic Follow-up Study.
(1996). An efﬁcient data clustering method for very large databases.
(2005). Blumenthal RS: Relation of serum uric acid with metabolic risk factors in asymptomaticmiddle-agedBrazilianmen.AmJCardiol 95:865–868,
(2006). Campbell LV: Relationship between inﬂammation, insulin resistance and type 2 diabetes: ‘cause or effect’? Curr Diabetes Rev 2:195–211,
(2007). Caprio S: The metabolic syndrome in children and adolescents. Lancet 369:2059–2061,
(2004). D’Agostino RB Sr, Wilson PW: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110:380–385,
(1999). ES: Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey,
(2006). Eschwege E: Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 49:2599–2603,
(1972). Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, withoutuseofthepreparativeultracentrifuge. Clin Chem 18:499–502,
(2001). ExecutivesummaryoftheThirdReportof The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497,
(2005). FordES,AjaniUA,MokdadAH:Themetabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28:878–881,
(1982). GidezLI,MillerGJ,BursteinM,SlagleS,Eder HA:Separationandquantitationofsubclasses ofhumanplasmahighdensitylipoproteinsby a simple precipitation procedure.
(2005). Glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112:2130–2137,
(2006). GS: Distribution and metabolicsyndromecorrelatesofplasmaC-reactive protein in biracial (black-white) youngeradults:theBogalusaHeartStudy. Metabolism 55:699–705,
(2007). GS: Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 56:792–798,
(2006). Inﬂammation and changes in metabolic syndrome abnormalities
(2005). Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42:987–1000,
(2007). LJ: Perinatal and childhood origins of cardiovascular disease.